US 11,987,577 B2
Therapeutic compounds and methods
Ashley Katana, Fairview Park, OH (US); and John Otto Link, San Francisco, CA (US)
Assigned to Actio Biosciences, Inc., San Diego, CA (US)
Filed by Actio Biosciences, Inc., San Diego, CA (US)
Filed on Aug. 1, 2023, as Appl. No. 18/363,195.
Application 18/363,195 is a continuation of application No. PCT/US2023/069762, filed on Jul. 7, 2023.
Claims priority of provisional application 63/385,282, filed on Nov. 29, 2022.
Claims priority of provisional application 63/359,715, filed on Jul. 8, 2022.
Prior Publication US 2024/0076294 A1, Mar. 7, 2024
Int. Cl. C07D 413/14 (2006.01); C07D 413/08 (2006.01)
CPC C07D 413/14 (2013.01) [C07D 413/08 (2013.01)] 20 Claims
 
1. A compound or salt selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
and salts thereof.